AstraSense is building a rapid, label-free diagnostic platform that reads the living metabolism of bacteria with light — so the right antibiotic can be chosen before resistance spreads.
Antimicrobial resistance is outpacing the tools used to diagnose it. Today, confirming which antibiotic will work still takes days — so treatment begins as an educated guess, and resistance keeps spreading.
Living bacteria carry a natural optical signature of their metabolism. AstraSense reads and amplifies that signature with light — distinguishing active cells from inactive ones, and revealing how bacteria respond to antibiotics far faster than growth-based testing allows.
Reads an intrinsic signal from the cells themselves — no stains, dyes, or added reagents.
Designed to deliver an answer in a fraction of the time that culture-based testing requires.
A platform built to move from the central laboratory toward the bedside, where speed matters most.
Hard-to-treat, multidrug-resistant infections are spreading faster than new antibiotics can be developed.
Advances in photonics and microfluidics have matured and fallen in cost, making compact, fast diagnostics feasible.
Antibiotic-stewardship programmes actively favour faster, evidence-based prescribing decisions.
Early rapid tests have validated demand — yet no approach has defined the standard of care.
A world where no patient waits days for the right antibiotic — where infections are matched to effective treatment in minutes.
Our mission is to read the living metabolism of bacteria with light — delivering rapid, label-free detection of infection and antibiotic resistance, and moving susceptibility testing from the central laboratory to the point of care.
A physician-scientist in medical microbiology with a track record of building diagnostics from the bench to manufacturing. Founder of AstraGene Group — the UAE's first molecular-diagnostics manufacturer — with deep experience across the science, production, and regulation of in-vitro diagnostics.
We are assembling a multidisciplinary founding team across photonics, microbiology, and engineering as the company grows.
Drawing on AstraGene Group's established GMP / ISO 13485 diagnostics manufacturing base.
Developed in collaboration with university research partners in photonics and microbiology.
Building the company and its team in Abu Dhabi's growing life-sciences ecosystem.
We welcome conversations with investors, clinical and research partners, and people who want to help bring rapid resistance testing to the point of care.
Get in touch →